Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy

Molecular Genetics and Metabolism

Volumn 104, Issue 3, 2011, Pages 279-283

  Terzis, Gerasimos ^a,b   Dimopoulos, Filippos ^c   Papadimas, George K ^b   Papadopoulos, Constantinos ^b   Spengos, Konstantinos ^b   Fatouros, Ioannis ^c   Kavouras, Stavros A ^d   Manta, Panagiota ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Aerobic training; Pompe disease; Resistance exercise

Indexed keywords

RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BICYCLE ERGOMETRY; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME REPLACEMENT; FEMALE; FORCE TRANSDUCER; FUNCTIONAL STATUS; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LEG; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; ONSET AGE; PRIORITY JOURNAL; PROTEIN DIET; RESISTANCE TRAINING; SHUTTLE WALK TEST; STRETCHING EXERCISE; TREATMENT DURATION; TREATMENT OUTCOME; WALKING;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BODY COMPOSITION; ENZYME REPLACEMENT THERAPY; EXERCISE; EXERCISE THERAPY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; WALKING;

EID: 82455162510     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.05.013     Document Type: Article

References (21)

1. Kishnani P.S., Steiner R.D., Bali D., Berger K., Byrne B.J., Case L.E., Crowley J.F., Downs S., Howell R.R., Kravitz R.M., Mackey J., Marsden D., Martins A.M., Millington D.S., Nicolino M., O'Grady G., Patterson M.C., Rapoport D.M., Slonim A., Spencer C.T., Tifft C.J., Watson M.S. Pompe disease diagnosis and management guideline. Genet. Med. 2006, 8:267-288.
2. Van der Ploeg A.T., Reuser A.J. Lysosomal storage disease 2. Lancet 2008, 372:1342-1353.
3. Katzin L.W., Amato A.A. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J. Clin. Neuromuscul. Dis. 2008, 9:421-431.
4. Kroos M.A., Manta P., Mavridou I., Muntoni F., Halley D., Van der Helm D., Zaifeiriou D., Van der Ploeg A., Reuser A., Michelakakis H. Seven cases of Pompe disease from Greece. J. Inherit. Metab. Dis. 2006, 29:556-563.
5. Müller-Felber W., Horvath R., Gempel K., Podskarbi T., Shin Y., Pongratz D., Walter M.C., Baethmann M., Schlotter-Weigel B., Lochmüller H., Schoser B. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul. Disord. 2007, 17:698-706.
6. Hagemans M.L., Hop W.J., Van Doorn P.A., Reuser A.J., Van der Ploeg A.T. Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 2006, 66:581-583.
7. Mellies U., Lofaso F. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir. Med. 2009, 103:477-484.
8. Little J.P., Phillips S.M. Resistance exercise and nutrition to counteract muscle wasting. Appl. Physiol. Nutr. Metab. 2009, 34:817-828.
9. Slonim A.E., Bulone L., Goldberg T., Mikekes J., Slonim E., Galanko J., Martiniuk F. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 2007, 35:70-77.
10. Rasebaka A., Lee A.L., Naughton M.T., Williams T.J., Holland A.E. The six minute walk test: a useful metric for the cardiopulmonary patient. Intern. Med. J. 2009, 39:495-501.
11. Cheung K., Hume P., Maxwell L. Delayed onset muscle soreness: treatment strategies and performance factors. Sports Med. 2003, 33:145-164.
12. Narici M.V., Roi G.S., Landoni L., Minetti A.E., Cerretelli P. Changes in force, cross sectional area and neural activation during strength training and detraining of the human quadriceps. Eur. J. Appl. Physiol. 1989, 59:310-319.
13. Kraemer W.J., Stone M.H., O'Bryant H.S., Conley M.S., Johnson R.L., Nieman D.C., Honeycutt D.R., Hoke T.P. Effects of single vs. multiple sets of weight training: impact of volume intensity and variation. J. Strength Cond. Res. 1997, 11:143-147.
14. Wokke J.H., Escolar D.M., Pestronk A., Jaffe K.M., Carter G.T., van den Berg L.H., Florence J.M., Mayhew J., Skrinar A., Corzo D., Laforet P. Clinical features of late onset Pompe disease: a prospective cohort study. Muscle Nerve 2008, 38:1236-1245.
15. Papadimas G., Terzis G., Papadopoulos C., Spengos K., Manta P. The importance of nutritional status in the prognosis of late onset Pompe disease. Mol. Genet. Metab. 2010, 100:389.
16. Enoka R.M. Neuromechanics of Human Movement 2002, Human Kinetics, Champaign, IL.
17. Case L.E., Kishnani P.S. Physical therapy management of Pompe disease. Genet. Med. 2006, 8:318-327.
18. Gross T.S., Poliachik S.L., Prasad J., Bain S.D. The effect of muscle dysfunction on bone mass and morphology. J. Musculoskelet. Neuronal Interact. 2010, 10:25-34.
19. Dalsky G.P., Stocke K.S., Ehasani A.A., Slatpolsky E., Lee W.C., Birge S. Weight-bearing exercise training and lumbar bone mineral content in post menopausal female. Ann. Intern. Med. 1988, 108:824-828.
20. Conroy B.P., Kraemer W.J., Maresh C.M., Dalsky G.P. Adaptive responses of bone to physical activity. Med. Exerc. Nutr. Health 1992, 64-74.
21. Johnstone A.M., Murison S.D., Duncan J.S., Rance K.A., Speakman J.R. Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am. J. Clin. Nutr. 2005, 82:941-948.